As we begin to reopen Rush University Medical Center for elective procedures and in-person care, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

Neurology — Clinical Trials

Alzheimer's Genetics Family Study

The Alzheimer's disease genetics initiative: The multiplex family study

ARAMIS Registry: Addressing Anticoagulant Management Issues in Stroke

ARAMIS Registry: Addressing anticoagulant management issues in stroke.

Cellular Autoimmune Mechanisms of Narcolepsy Study

Study on the cellular autoimmune mechanisms of narcolepsy.

Chorea Associated with Huntington’s Disease Treatment Study

A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of valbenazine for the treatment of chorea associated with Huntington’s disease.

Drug Treatment Study for Multiple Sclerosis Relapse

Study of an experimental biological drug product compared to placebo administered one time as an infusion in subjects with multiple sclerosis experiencing a relapse.

Epilepsy Neuronal Changes Study

Neuronal changes in intractable epilepsy

Epilepsy Phenome/Genome Project (EPGP)

Epilepsy phenome/genome project (EPGP)

Fragile X Investigational Drug Study (Adult)

An open-label study to evaluate the long-term safety and efficacy of an investigational drug in adults with fragile X syndrome

Fragile X Syndrome Treatment with MC01CI Study

A six-week, randomized, multicenter, double-blind, parallel, flexed- and fixed-dose study of MC01CI (Metadoxine Extended-Release) 700 mg and 1400 mg compared with placebo in adults and adolescents with fragile X syndrome